Miltenyi Biomedicine
Maria Victoria Arguissain is a professional with experience in business strategy, analytics, and forecasting. Maria Victoria has worked in various roles such as Consulting Analyst at IQVIA, Staff Tax Accountant at EY, and Assistant Professor of Economics at Universidad del CEMA. Maria Victoria is currently a working student at Miltenyi Biomedicine, where Maria Victoria utilizes their skills in quantitative and qualitative analysis to develop client-specific solutions. With a Bachelor's degree in Economics from Universidad del CEMA and currently pursuing a Master's degree in Economics from The University of Bonn, Maria Victoria has a strong educational background to support their professional experiences.
This person is not in any teams
Miltenyi Biomedicine
2 followers
Miltenyi Biomedicine is a biopharmaceutical company that develops innovative cell and gene therapies. We are committed to bring cancer treatments and regenerative therapies to patients with unmet medical needs worldwide. We work in partnership with physicians and other healthcare providers to expand access to new therapies. Our clinical research program includes: CAR T, CAR NK, our proprietary Adapter CAR™ and induced pluripotent stem cells (iPSC) technologies. For more information, please visit our website at www.miltenyibiomedicine.com.